Physicochemical Properties
| Molecular Formula | C14H19BO4 |
| Molecular Weight | 262.11 |
| Exact Mass | 262.137 |
| CAS # | 346656-34-6 |
| PubChem CID | 10332902 |
| Appearance | Colorless to light yellow liquid |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 384.8±25.0 °C at 760 mmHg |
| Flash Point | 186.5±23.2 °C |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.499 |
| LogP | 1.631 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 19 |
| Complexity | 309 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O1B(C2=C([H])C([H])=C([H])C([H])=C2C(=O)OC([H])([H])C([H])([H])[H])OC([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
| InChi Key | GZHASWCTAWNFFW-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C14H19BO4/c1-4-17-13(16)11-7-5-6-8-12(11)15-18-9-14(2,3)10-19-15/h5-8H,4,9-10H2,1-3H3 |
| Chemical Name | ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | HSL[1]. |
| References |
[1]. PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF. US7037905. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (381.52 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (7.94 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (7.94 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (7.94 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.8152 mL | 19.0760 mL | 38.1519 mL | |
| 5 mM | 0.7630 mL | 3.8152 mL | 7.6304 mL | |
| 10 mM | 0.3815 mL | 1.9076 mL | 3.8152 mL |